␥␦ T cells are the first T cells to develop, can be found in sites of entry into the body (epithelial cell-associated tissues, such as gut and pulmonary mucosa), accumulate during inflammation, and are thought to be involved in innate immune responses against a wide spectrum of pathogens [1] [2] [3] [4] . In epithelial cell-associated tissues and sites of inflammation, cells of the innate immune system, such as myeloid cells, epithelial cells, dendritic cells, and some specialized T cells, including ␥␦ T cells, can encounter invading microbes via recognition of pathogen-associated molecular patterns (PAMPs) [5] [6] [7] . In ␥␦ T cells, PAMPs, such as crude lipopolysaccharide (LPS) preparations, induce selective expression of some chemokines, such as macrophage-inflammatory protein-1␣ (MIP-1␣) and MIP-1␤ [7] . In global gene expression analyses, we found that bovine ␥␦ T cells express transcripts for a number of different PAMP receptors, including scavenger receptors (such as CD36), Toll-like receptors (TLRs), and CD11b, among others [7] . The importance of these receptors in PAMP responses by ␥␦ T cells has not been characterized.
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The CD36 PAMP receptor is a member of the scavenger receptor family of leukocyte antigens. It is thought to be restricted to monocytes and endothelial cells and serves as a receptor for oxidized lipids, apoptotic cells, thrombospondin-1, and Plasmodium falciparum-parasitized erythrocytes [8 -10] . As mentioned above, CD36 has been shown to facilitate monocyte TLR2 responses against lipoteichoic acid (LTA), analogous to the role CD14 plays in facilitating TLR4 recognition of LPS [10] . It is interesting that CD36 is quite restrictive in its effect on TLR2 function, enhancing TLR2/TLR6 ligand (LTA) but not TLR2/TLR1 ligand {the synthetic triacylated lipopeptide N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-(R)-cysteine (PAM 3 CSK 4 ) interactions [10] . In this report, we tested the hypothesis that CD36 serves a similar function on ␥␦ T cells.
In agreement with our earlier study [7] , CD36 transcripts were detected in resting, sorted ␥␦ T cells (Fig. 1) . As also seen in our earlier study [7] , stimulation of ␥␦ T cells, in this case with PMA/ionomycin for 4 h, increased the level of detectable CD36 mRNA (Fig. 1 ). CD36 protein expression in Fig. 1 . Bovine ␥␦ T cells expressed CD36 mRNA, which increased following phorbol 12-myristate 13-acetate (PMA)/ionomycin stimulation. ␥␦ T cells were purified from bovine (1-6 month-old males; 17 total for the entire study) peripheral blood mononuclear cell (PBMC) preparations to Ͼ95% using an antibody/magnetic cell sorter (MACS) magnetic bead cell separation protocol and cultured as described previously [7] . The cells were then treated with 20 ng/ml PMA and 0.5 g/ml ionomycin or phosphate-buffered saline (PBS; resting) for 4 h. RNA was extracted, and real-time reverse transcriptasepolymerase chain reaction (RT-PCR) was performed, as described [7] , using bovine-specific CD36 primers. Results reflect means Ϯ SD of three replicates. Results are representative of three individual experiments.
bovine ␥␦ T cells was examined by fluorescence-activated cell sorter (FACS) and immunohistochemical analyses using an anti-human CD36 monoclonal antibody (mAb), which crossreacts with bovine CD36 [9] . Anti-CD36 mAb stained a fraction of resting peripheral blood ␥␦ T cells, which was repeated in cells from four different calves ( Fig. 2A) . PMA/ionomycin treatment increased surface expression of CD36 on ␥␦ T cells, which was detectable at 24 h. After 72 h, nearly all ␥␦ T cells were CD36-positive following PMA/ionomycin stimulation (Fig. 2B) . A few non-␥␦ T cells also expressed CD36, but this fraction was highly variable between samples, and it is unclear at this time whether they were natural killer cells, a small subset of ␣␤ T cells, or even B cells (data not shown). Intracellular CD36 was examined by staining acetone-fixed cytospin preparations of sorted, resting, and 72 h PMA/ionomycinstimulated ␥␦ T cells (72 h was chosen based on the FACS analyses shown in Fig. 2) . In contrast to the expression of CD36 on only a fraction of resting ␥␦ T cells detected by FACS (Fig.  2) , most resting ␥␦ T cells in cytospin preparations were CD36-positive, suggesting they expressed CD36 within intracellular granules (Fig. 3) . Following PMA/ionomycin activation for 72 h, there was an obvious increase in staining, suggesting new protein synthesis and based on the FACS analysis (Fig. 2) , translocation of the intracellular pools to the cell surface (Fig. 3) . Western blot analysis showed the anti-CD36-reactive molecule on ␥␦ T cells to be the predicted molecular mass of CD36 (ϳ80 kDa, data not shown). These results document that ␥␦ T cells express intracellular and cell surface forms of the CD36 protein and that activation leads to an increase of the cell surface molecule.
In earlier studies, we found that bovine ␥␦ T cells increase transcript levels for MIP-1␣ following 4 h stimulation with PAMPs, such as peptidoglycan and LPS [7] and LTA (unpublished observations). To test whether CD36 contributes to the recognition of LTA by ␥␦ T cells, as recently shown for monocytes [10] , we used the conditions of our earlier assays and tested the effect of anti-CD36 mAb versus an isotypematched, negative control mAb. As seen before for other PAMPs [7] , ␥␦ T cells from different animals displayed variable responses to LTA, but in each case where LTA induced MIP-1␣ up-regulation, anti-CD36 mAb, but not the negative Fig. 2 . CD36 surface expression increases on ␥␦ T cells following stimulation with PMA/ionomycin. Two-color flow cytometry was performed using standard protocols, as described previously [4] . Briefly, cells were stained sequentially with 20 g/ml anti-CD36 mAb, phycoerythrin (PE)-conjugated goat anti-mouse, 10% mouse serum, and fluorescein isothiocyanate-conjugated GD3.8 (anti-pan ␥␦ T cell). All FACS was done on a BD FACSCalibur using Cell Quest software. ␥␦ T cells were purified by panning on E-selectin cDNA L-cell transfectants, as described previously [11] , which yielded a preparation of Ͼ85% pure ␥␦ T cells without surface antibody, as occurred with the MACS separation protocol described in Figure 1 . Cytospin slide preparations of resting or 72 h PMA/ionomycin-stimulated, purified ␥␦ T cells were prepared, blocked in PBS containing 5% goat serum, and stained with 20 g/ml anti-CD36 or GD3.8 anti-␥␦ T cell mAb, and primary mAb was detected by addition of goat anti-mouse peroxidase-conjugated secondary antibody and 3-amino-9-ethylcarbazole developing solution (TAGO, Inc., Fort Wayne, IN). Anti-CD36-stained resting ␥␦ T cells (A), anti-CD36 (B), and GD3.8-stained ␥␦ T cells (C) treated with PMA/ionomycin for 72 h and second stage-alone, negative control (D) are shown. Images were taken at 40ϫ original magnification.
control mAb, blocked the effect (Fig. 4 and data not shown) . The anti-CD36 mAb effect was specific to TLR2/TLR6 function in that responses to PAM 3 CSK 4 (TLR2/TLR1 agonist) were not affected (Fig. 4) .
Our results demonstrate for the first time that ␥␦ T cells express CD36 at the RNA, protein, and functional level. CD36 is expressed on resting ␥␦ T cells, but surface levels increase considerably following PMA/ionomycin treatment. Consistent with recent findings for monocytes, CD36 facilitates ␥␦ T cell responses to LTA [10] . This interaction likely requires TLR2/ TLR6, although this awaits formal demonstration. Additional studies are under way to test whether ␥␦ T cell CD36 also functions as a receptor for oxidized low-density lipoproteins and/or apoptotic cells, other activities attributed to the monocyte molecule [8] . Expression of CD36 on ␥␦ T cells is consistent with and provides additional support to the role of these cells in innate immunity. Fig. 4 . Anti-CD36 mAb blocked LTA-induced increase in MIP-1␣ mRNA expression in ␥␦ T cells, which were purified from bovine PBMC preparations to Ͼ95% using an antibody/MACS magnetic bead cell separation protocol as described in Figure 1 . Purified ␥␦ T cells were stimulated with 10 g/ml LTA or 10 g/ml PAM 3 CSK 4 in the presence or absence of anti-CD36 mAb or an isotype-matched, negative control mAb (IgM, Immunoglobulin M) (10 ug/ml) for 4 h. RNA was extracted, and real-time RT-PCR was performed as described [7] using MIP-1␣-specific primers. Results reflect mean Ϯ SD from three replicates and are representative of three different experiments.
